One of the first lncRNAs to be described in PCa was prostate cancer gene expression marker 1 (PCGEM1), a lncRNA that inhibits apoptosis and promotes cell proliferation in vitro via enhanced androgen-dependent gene transcription [161]. The gene discussed is PCGEM1; the disease is posterior cortical atrophy.